NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
- State
- Under way
- Phase
- Phase 3
- People
- 17,300 planned
- Started
- 5 Mar 2024
- Primary completion
- Mar 2029
- Arms
- Lepodisiran Sodium
- Results
- None posted
- 4 Mar 2024: Trial registered
- 5 Mar 2024: Trial started